SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-039121
Filing Date
2019-02-14
Accepted
2019-02-14 06:28:02
Documents
2
Group Members
AMIR NASHATBRIAN CHEEBRYCE YOUNGRENDAVID BARRETTPOLARIS ENTREPRENEURS' FUND VII, L.P.POLARIS MANAGEMENT CO. VII, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d699215dsc13da.htm SC 13D/A 133556
2 EX-99.A d699215dex99a.htm EX-99.A 10965
  Complete submission text file 0001193125-19-039121.txt   146356
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89552 | Film No.: 19600505
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210 855-787-3500
Polaris Partners VII, L.P. (Filed by) CIK: 0001611189 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A